CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 80 enrolled
Drug / intervention
Sculptra Aesthetic 8ml +1 moredevice
Likely dose
Sculptra Aesthetic 8mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03780244
NCT03780244N/ACompleted

A Randomized, Evaluator-blinded, Multi-center Study to Evaluate the Safety and Effectiveness of Sculptra Aesthetic for Correction of Nasolabial Folds.

Galderma R&D·interventional·Posted Dec 19, 2018·Updated Nov 14, 2022

In Brief

A clinical study evaluating Sculptra Aesthetic 8ml and Sculptra Aesthetic 5ml for Nasolabial Folds. Completed, enrolled 80 participants across 5 sites.

Detailed Summary

This study has been designed to evaluate the safety of Sculptra Aesthetic as a single regimen for correction of Nasolabial Fold (NLF) contour deficiencies after changes in reconstitution and injection procedures compared to the approved label.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedDec 19, 2018
Enrollment StartDec 18, 2018
Primary CompletionFeb 28, 2020
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 7.5 years ago

Interventions

Sculptra Aesthetic 8mldevice

Treatment of nasolabial folds

Sculptra Aesthetic 5mldevice

Treatment of nasolabial folds